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Purpose: We have previously shown that an imaging marker, increased periventricular [11C]ﬂumazenil ([11C]
FMZ) binding, is associated with failure to become seizure free (SF) after surgery for temporal lobe epilepsy
(TLE) with hippocampal sclerosis (HS). Here, we investigated whether increased preoperative periventricular
white matter (WM) signal can be detected on clinical [18F]FDG-PET images. We then explored the potential of
periventricular FDGWM increases, as well as whole-brain [11C]FMZ and [18F]FDG images analysed with random
forest classiﬁers, for predicting surgery outcome.
Methods: Sixteen patients with MRI-deﬁned HS had preoperative [18F]FDG and [11C]FMZ-PET. Fifty controls had
[18F]FDG-PET (30), [11C]FMZ-PET (41), or both (21). Periventricular WM signal was analysed using Statistical
Parametric Mapping (SPM8), and whole-brain image classiﬁcation was performed using random forests imple-
mented in R (http://www.r-project.org). Surgery outcome was predicted at the group and individual levels.
Results: At the group level, non-seizure free (NSF) versus SF patients had periventricular increases with both
tracers. Against controls, NSF patients showed more prominent periventricular [11C]FMZ and [18F]FDG signal in-
creases than SF patients. All differencesweremoremarked for [11C]FMZ. For individuals, periventricularWMsig-
nal increases were seen at optimized thresholds in 5/8 NSF patients for both tracers. For SF patients, 1/8 showed
periventricular signal increases for [11C]FMZ, and 4/8 for [18F]FDG. Hence, [18F]FDGhad relatively poor sensitivity
and speciﬁcity. Random forest classiﬁcation accurately identiﬁed 7/8 SF and 7/8 NSF patients using [11C]FMZ im-
ages, but only 4/8 SF and 6/8 NSF patients with [18F]FDG.
Conclusion: This study extends the association between periventricular WM increases and NSF outcome to clin-
ical [18F]FDG-PET, but only at the group level. Whole-brain random forest classiﬁcation increases [11C]FMZ-PET3s
performance for predicting surgery outcome.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Around one-third of patients with epilepsy are refractory to medical
treatment, and epilepsy surgery is an efﬁcient therapeutic alternative
for some of these patients. Resection surgery is indicated in some focal
epileptic syndromes, including mesial temporal lobe epilepsy (mTLE),
a common form of adult epilepsy that is often resistant to anti-
epileptic drugs (AEDs) and frequently associated with hippocampal
sclerosis (HS) (Engel et al., 2003; Spencer andHuh, 2008). Nevertheless,59 Boulevard Pinel, Lyon/Bron
(J. Yankam Njiwa).
. This is an open access article underabout one-third of patients with HS are not seizure free (NSF) after ep-
ilepsy surgery. There is therefore a need of ﬁnding relevant biomarkers
to anticipate the risk of suboptimal surgery outcome.
The presence of unilateral HS on presurgicalmagnetic resonance im-
aging (MRI) ipsilateral to surgery predicts a favourable, i.e. seizure free,
outcome (Jeong et al., 2005), as does focal hypometabolism on [18F]
ﬂuorodeoxyglucose positron emission tomography (FDG-PET) ipsilater-
al to affected temporal lobe (Malmgren and Thom, 2012).
Other potential biomarkers have been investigated for the predic-
tion of TLE-HS surgery outcome and ﬁndings are not always consistent
(Aull-Watschinger et al., 2008; Janszky et al., 2005). For example, anal-
ysis of the ictal semiology as recorded by scalp video-EEG has shown
that extra temporal features do not correlate with surgical outcome inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Clinical data for 16 patients with refractorymTLE and HS. Upper half: seizure free patients; lower half: non-seizure free patients. Imaging based predictors for seizure status are colour-coded, with green indicating that the particular marker correctly
predicted the individual patient3s outcome class according to the method used in that column (see text for details).
Patient Age/sex Onset/duration
of epilepsy
(years)
HS Follow-up
(months)
Medication at
operation. *: reduced. **:
stopped (medication
restarted)
Outcome
(Engel class)
FDG
hypometabolism
on SPM
[11C]FMZ-PET increases
in periventricular areas
(threshold = 0.01,
z N 3.2, p b 0.46)
[18F]FDG-PET increases
in periventricular areas
(threshold = 0.01,
z N 3.2, p b 0.5)
RF prediction
(FMZ)
RF prediction
(FDG)
Additional
information
#1 24/f 6/18 L 31 LEV, LTG* IA Yes None L ant front lobe
z = 3.89 (−14 28 2),
3.2 cm2
True False L temporal–occipital
dysplasia
#2 22/f 2/20 L 58 CBZ, TPM, CLB** IA Yes None None False False
#3 27/m 4/23 L 35 CBZ, VPA, CLB** IA Yes None None True True
#4 36/f 3/33 L 98 CBZ, LTG, TPM** IA Yes None L ant front lobe
z = 4.24 (−24 32−2),
2.2 cm3
R ant front lobe
z = 3.81 (16 32−6),
1.7 cm3
True True L temporal pole
signal
abnormalities +
discrete
dysgenesis of left
amygdala
#5 46/f 12/34 L 52 PB, PRG, LEV* IA No None R ant front lobe
z = 3.24 (4 22−4),
2.4 cm3
True True
#6 26/f 5/21 R 112 CBZ, CLB, PB* IA No R lat of ventricle z = 4.18
(42−36 8), 2.2 cm3
L lateral of ventricle
z = 6.02 (−34−42 16),
5.3 cm3. R ant front
lobe z = 4.66
(18 28 4), 10.4 cm3. R
lateral of ventricle
z = 3.7 (18–22 32),
2.2 cm3
True False R temporal pole
signal
abnormalities
#7 48/f 6/42 R 81 CBZ, CLB** IA Yes None None True True
#8 30/f 5/25 R 24 CBZ, TPM, CLB, LEV** IA Yes None None True False
#9 46/f 33/13 R 23 PHT, LEV, PB** IB Yes None Lateral of
posterocentral portion
of R lateral ventricle
z = 3.76 (30–34 22),
1.6 cm2
True False
#10 36/f 3/33 R 116 CBZ, PB, CLB IVB No None None True True Seizure onset right
temporal and right
insular on SEEG
#11 29/f 4/25 R 44 CBZ, CLB** IIA Yes None None True True Small symmetric
hippocampi
and temporal
pole signal
abnormalities on
MRI (FDG, SEEG
unilateral R)
(continued on next page)
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Table 1 (continued)
Patient Age/sex Onset/duration
of epilepsy
(years)
HS Follow-up
(months)
Medication at
operation. *: reduced. **:
stopped (medication
restarted)
Outcome
(Engel class)
FDG
hypometabolism
on SPM
[11C]FMZ-PET increases
in periventricular areas
(threshold = 0.01,
z N 3.2, p b 0.46)
[18F]FDG-PET increases
in periventricular areas
(threshold = 0.01,
z N 3.2, p b 0.5)
RF prediction
(FMZ)
RF prediction
(FDG)
Additional
information
#12 32/m 5/27 L 119 PB, CLB** (LEV, CLB) IIA No Widespread WM
increases with the
maximum L ant of frontal
horn z = 6.02 (−20 34
−4), 15.3 cm3 but
extending bilaterally
with other maxima
anterior to both frontal
horns and postero-lateral
of right lateral ventricle.
Lateral of posterocentral
portion of L lateral
ventricle z = 4.62 (−34
−44 14), 3.7 cm3. Lateral
of posterior portion of R
lateral ventricle z = 4.12
(30 –60 12), 6.5 cm3
Widespread WM increases
with the maximum R lat
ventricle z = 5.62 (30–34
20), 5.02 cm3 but
extending bilaterally with
other maxima to the lateral
ventricle z = 4.92 (−36
−42 16), 7.0 cm3. R ant
front lobe z = 3.73 (26 32
10), 2.2 cm3
True True
#13 32/f 11/21 L 89 CLB, CBZ** (CBZ, PB) IID No Lateral of anterocentral
portion of R frontal horn
z = 3.27 (24 12 16),
4.0 cm3. L anterior of
frontal horn z = 3.82
(−18 36−4), 5.0 cm3
R anterior of frontal horn
z = 3.24 (24−6 28),
1.9 cm3
False True
#14 22/m 9/13 L 72 CBZ, TPM, PB, CLB** ID Yes Lateral of posterocentral
portion of L lateral
ventricle z = 4.51 (−34
−48 16), 1.7 cm3. L
anterior of frontal horn
z = 3.96 (−14 38−2),
1.7 cm3
L ant front lobe z = 5.79
(−12 36−2), 5.5 cm3.
L sup cella media post horn
z = 4.7 (−32−50 18),
3.6 cm3
True True
#15 39/m 1/38 L 67 TPM, PB* IIA No Lateral and inferior of L
ventricle where temporal
and occipital horns
originate z = 4.01 (−30
−52 4), 3.0 cm3. Lateral
and inferior of R ventricle
z = 3.29 (10 6 4), 2.4 cm3
Lateral postorocentral
portion of R lateral
z = 5.11 (24−38 4),
7.3 cm3. L occipital horn
z = 4.648 (−28−50 6),
4.4 cm3
True False
#16 41/f 3/38 R 78 LTG, CBZ, PB* IC No Lateral and inferior of R
ventricle where temporal
and occipital horns
originate z = 3.22
(32−48 4), 1.8 cm3
None True True Moderated gliosis
R temporal pole,
L ventricular
enlargement
AP = amisulpride, AZL = alprazolam, PB = phenobarbital, CBZ = carbamazepine, CLB = clobazam, CP = codeine paracetamol, DHGT= dihidroergotamine, EXD= enroﬂoxacine+diclofenac Enromax, FA = folic acid, GBP = gabapentin, GVG=
vigabatrin, HDZ = hydroxyzine, LEV = levetiracetam, LTG = lamotrigine, OXC = oxcarbazepine, PB = phenobarbital, PBA = phenobarbital with amphetamine, PHT = phenytoin, PPN = pipampérone, PVT = pravastatin, PX = paroxétine, PZ =
Prozac, TGB = tiagabine, TPM= topiramate, VPA = valproic acid.
Postoperative outcomes for non-seizure free patients are given in the footnotes, including times when the outcome class changed. [11C]FMZ-PET results were previously presented (Yankam Njiwa, 2013 #6038) and are repeated here for
comparison.Clusters are characterized by peak voxel z score (MNI coordinates), and cluster extent.
M=male, f = female, HS= hippocampal sclerosis.1IB at 5 months and IA at 17 months. 2Never seizure free. 3IB at 5, 10, 23 months, ID at 16 months and IA at 29 and 35 months. 4IA until 110 months. 5IA at 19 months and IID at 31 months. 6ID at
60 months. 7IIA at 67 months. 8IC at 12 and 21 months.
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125J. Yankam Njiwa et al. / NeuroImage: Clinical 7 (2015) 122–131patients with temporal lobe epilepsy and HS (Borelli et al., 2008). How-
ever, other studies have found extratemporal features as relevant prog-
nostic factors for predicting outcome after TLE-HS surgery (Ferrari-
Marinho et al., 2012; Najm et al., 2013; Ryvlin and Kahane, 2005).
Hence the search of prognostic features is important for identifying re-
liable predictors of suboptimal outcome as a tool for patient manage-
ment and counselling, including for avoiding invasive EEG prior to
surgery when possible.
PET has long been used for helping to localize the seizure-onset area,
especially in TLE (Engel et al., 1990). The most common PET tracer used
is [18F]FDG, which measures regional glucose metabolism (Henry et al.,
1993). [11C]ﬂumazenil (FMZ) which binds to the benzodiazepine sites
of GABAA receptors has been used for predicting surgery outcome in
mTLE-HS. Previous studies have shown that increased preoperative
periventricular white matter (WM) FMZ binding was associated with
NSF outcome after temporal lobe resection for HS. This was shown at
the group level using volume-of-distribution images (Hammers et al.,
2005) and, with a larger control group, at the individual level using
summed images (YankamNjiwa et al., 2013). The tentative explanation
for this association is that increased periventricular binding relates to
heterotopic neurons, i.e. a mild form of migration disorder not visible
on MRI (Hammers et al., 2003).
Furthermore, in a number of papers, investigation of WM [11C]FMZ
volume-of-distribution (VT) by voxel-based analysis has shown a strong
correlation between WM [11C]FMZ VT and the number of heterotopic
neurons histologically determined in the WM (Hammers et al., 2001;
Hammers et al., 2002). PET analysed with SPM detected periventricular
[11C]FMZ VT increases in MRI-negative patients with extratemporal ep-
ilepsywhichwere analogous to such increases when analysingMRI vis-
ible periventricular heterotopia (Hammers et al., 2003).
In the present study, we ﬁrst investigated whether increased preop-
erative WM FDG uptake could also be used for predicting epilepsy sur-
gery outcome. We then assessed if an advanced machine learning
technique (random forests (RF); Breiman, 2001) could predict seizure
outcome based on voxel-wise signal intensities from preoperative FDG
and FMZ whole brain images. Finally, both methods were compared.
2. Material and methods
2.1. Participants
Patients were retrospectively identiﬁed for the study and fulﬁlled
the following criteria: 1) suffering from mTLE, 2) HS diagnosed on
MRI (conﬁrmed by histopathology for thirteen of the patients), 3) tem-
poral lobe surgery with a postsurgical follow up for at least 12 months,
4) availability of preoperative [18F]FDG PET and [11C]FMZ PET on the
Siemens/CT HR+ PET camera installed at the CERMEP imaging centre.
Patient details have been described in a previous study on [11C]FMZ
PET alone (Yankam Njiwa et al., 2013). Brieﬂy, sixteen patients (twelve
women) fulﬁlled the criteria. Nine had left-sided HS and six right-sided
HS, diagnosed on MRI by an experienced radiologist and conﬁrmed by
an experienced neurologist. Outcomewas assessed according to Engel3s
classiﬁcation (Engel, 1987) by an epileptologist blinded to the imaging
results (PR), for the time point of assessment. Eight patients (50%)
were entirely seizure free (SF; Engel class IA) and eight were not
(NSF; not Engel class IA either continuously or at some stage during
follow-up, at least 4 months after surgery) (Takahashi et al., 2012).
Table 1 shows the clinical characteristics of the patients.
Data were available for the following non-imaging potential out-
come predictors: age at onset, duration of epilepsy, age at operation.
Fifty control subjects with a mean age of 35 ± 10 years were avail-
able for this study. Forty-one had [11C]FMZ PET scans (20 men and 21
women), and 30 had [18F]FDG scans (21 men, 9 women). Twenty pa-
tients had both FMZ and FDG-PET scans. All images were acquired on
the same camera. All controls had normal MRI and were not treated
with any regular medication.All subjects had signed written informed consent at the time of PET
scanning in agreementwith the French legislation and after approval by
the local Ethics committee.
2.2. PET data acquisition
Three-dimensional PET scans were acquired on an Exact ECAT HR+
scanner (Siemens, Erlangen, Germany) with a full width half maximum
(FWHM) spatial resolution of about 5 mm3 (Brix et al., 1997). A 68Ge
transmission scan was acquired for attenuation correction.
FMZ (RO 15-1788) was radiolabelled with 11C via methylation
(Maziere et al., 1984). Unlabelled FMZ (0.01 mg/kg) and [11C]FMZ
(2.775 MBq/kg) were injected simultaneously (Delforge et al., 1995),
and twelve frames of increasing length were acquired over 55 min
(for details, see (Yankam Njiwa et al., 2013)). Summed [11C]FMZ radio-
activity images were obtained from the attenuation and scatter
corrected dynamic 3D series over the last ﬁve frames (20–55 min post
injection), as these have been shown to yield particularly reliable mea-
sures (Bouvard et al., 2012).
The protocol for FDG-PET imaging consisted of a simultaneous injec-
tion of an 18.5MBq load dose in addition to 1.5MBq/kg dose of [18F]FDG
followed by the acquisition of static images 40–50 min post injection.
2.3. PET data analysis
[11C]FMZ summed radioactivity images and static [18F]FDG images
were ﬁrst analysed using statistical parametric mapping (SPM8;
Wellcome Department of Imaging Neuroscience, UCL, London, UK;
http://www.ﬁl.ion.ucl.ac.uk/spm) and speciﬁc periventricular masks
(Hammers et al., 2005; Yankam Njiwa et al., 2013). Voxel-wise PET
signal intensities across the whole brain were then used for RF
classiﬁcation.
For group analyses, the images of the seven right HS patients (3/8 SF
and 4/8 NSF) were right–left reversed prior to spatial normalization to
lateralize the epileptogenic side to the left for all patients.
In-house [11C]FMZ and [18F]FDG templates in the standardMontreal
Neurological Institute (MNI) space based both on over thirty ﬁve
healthy subjects scanned on the same scanner were available. Because
a proportion of the raw images had been left–right reversed, these tem-
plates were symmetrized for group analyses and RF classiﬁcation as de-
scribed earlier (Didelot et al., 2010). All images of the study were
spatially normalized (Ashburner and Friston, 1999) to the correspond-
ing symmetric template for the appropriate tracer (either [11C]FMZ or
[18F]FDG). The resulting spatially normalized images were smoothed
using an isotropic Gaussian kernel of 10 mm FWHM.
For individual analyses with SPM8, the original, asymmetric [11C]
FMZ and [18F]FDG templates were used, i.e. individual images were
not ﬂipped. The preprocessing was otherwise identical.
Global means, i.e. the average radioactivity across the brain deter-
mined within a mask consisting of the voxels with intensity above 1/8
of the mean of all voxels in the matrix, were compared between SF pa-
tients, NSF patients and controls using two-tailed student t-tests.
2.3.1. SPM analyses of periventricular WM increases
For SPM8analysis, entireWMwas extracted through combination of
two masks and the assessment of periventricular regions was per-
formed using a mask constructed with basic SPM8 functions, for more
details see (Hammers et al., 2005; Yankam Njiwa et al., 2013). A covari-
ance group speciﬁc analysis (ANCOVA)model was utilized for global ra-
dioactivity correction.
Periventricular increases were assessed within the mask introduced
above in the group and individual analyses. We aimed to replicate the
earlier ﬁnding of periventricular WM increases of [11C]FMZ binding in
patients with suboptimal outcome relative to SF patients and controls,
using the much more widely used PET tracer [18F]FDG.
126 J. Yankam Njiwa et al. / NeuroImage: Clinical 7 (2015) 122–131At the individual level, each patient was compared against all 30
[18F]FDG controls in order to investigate whether preoperative
periventricular increases can be used to predict postoperative outcome
for a given patient. Several combinations of the characteristics of clus-
ters with increased periventricular WM signal were evaluated for the
best separation of SF and NSF patients, namely “uncorrected cluster
probability” and “z value of peak voxel” (Yankam Njiwa et al., 2013).
A given search space between 0.00 and 0.99, with moving steps of
0.01, for cluster probability and a level of signiﬁcance of the peak
voxel z score set at any value above 3.2, step of 0.02 was set. The ability
to optimally discriminate SF and NSF was tested for all combinations
and after screening the cluster p values.
2.3.2. SPM analyses of mesial temporal [18F]FDG hypometabolism
Presence of focal hypometabolism on presurgical FDG-PET ipsilater-
al to affected temporal lobe has been shown to predict favourable
surgical outcome (Malmgren and Thom, 2012). We have therefore
investigated the signiﬁcance of mesial temporal lobe [18F]FDG
hypometabolism as a predictor of postsurgical outcome in this study.
Each patientwas compared against all 30 [18F]FDG controls and clusters
with a peak voxel z score ≥3.2 and a p value ≤0.5 were considered
signiﬁcant.
2.3.3. Random forest classiﬁcation based on whole-brain PET signal
intensities
We investigated the capabilities of random forest (RF) classiﬁers to
distinguish patients who became SF and those who remained NSF
from each other and from controls based on voxel-wise signal intensi-
ties across the full brain volumes for both [11C]FMZ and [18F]FDG PET
images.
Each subject served as a test dataset for the training set composed of
the remaining subjects acquiredwith each tracer. Feature data from im-
ages acquired with each tracer were independently used as inputs to an
RF classiﬁer.
RF is an ensemble classiﬁer, consisting ofmany decision trees, which
outputs the class that is the result of combining the prediction by indi-
vidual trees (Breiman, 2001). Random forests combine bootstrap aggre-
gation (bagging) (Breiman, 1996) and random feature selection (Amit
and Geman, 1997; Ho, 1998) to construct a collection of decision trees
exhibiting controlled variations. The training set for each individual
tree in a random forest is constructed by sampling N examples (sub-
jects) at random with replacement from the N available examples in
the dataset. After drawing N bootstrap samples from the original data,
an ‘unpruned’ decision tree is grown as follows: at each node, rather
than choosing the best split among all predictors, randomly sample
mtry of the predictors and choose the best split from among those vari-
ables. New data are classiﬁed by aggregating the predictions of the Ntree
trees, in the case of classiﬁcation considering the majority of votes.
Tree nodes are split based on the Gini index (Breiman et al., 1984),
which measures the likelihood of an example to be incorrectly labelled
if it was randomly classiﬁed according to the distribution of labels with-
in the node. A measure of the importance of an individual feature for
classiﬁcation can be computed by summing the decreases in the Gini
index occurring at all nodes in the forest, which are partitioned based
on that feature.
For the classiﬁcation results presented in this study, the implemen-
tation of random forests in the statistical software package R, a port ofTable 2
Global values (mean± SD), in Bq/ml, computed for summed radioactivity images (FMZ) and F
comparison of different patient groups and control group. The absolute difference in values be
FDG
NSF SF Con
Before normalization 2064 ± 946 (p = 0.03) 2290 ± 986 (p = 0.09) 299
After normalization 3268 ± 1807 (p = 0.22) 3233 ± 1360 (p = 0.11) 415Leo Breiman and Adele Cutler3s original Fortran code by Andy Liaw
and Matthew Wiener, version 4.6–6 (http://cran.r-project.org/web/
packages/randomForest), was used.
At each forest were grown [1000:step:10,000] trees in steps of 1000.
The datasets were ﬁrst tuned, with the speciﬁc class implemented in R
(rftune), to seek for the optimal number of features (computing the
smallest error value) to be selected at each tree node according to the
number of available features. The number of features thus computed
at each node was 714 for FMZ and 15 for FDG.
3. Results
3.1. Global values
The global values of the summed radioactivity images differed
signiﬁcantly between the NSF and controls groups before spatial nor-
malization for FDG. After spatial normalization, i.e. on the images used
for the present analyses, these values did not differ signiﬁcantly
(pmin = 0.11). Table 2 illustrates the results.
3.2. Group analyses
3.2.1. NSF versus SF patients restricted to WM periventricular signal
increases
Higher periventricular ligand uptake was visualized in NSF patients
in comparison to SF patients for both tracers. Areas of high [18F]FDG
binding were observed around the posterior horn of the ventricles con-
tralateral to the seizure focus (zmax = 3.37, 0.4 cm3) and ipsilaterally
(zmax=3.66, 1.1 cm3). [18F]FDGuptakewas increased at very similar lo-
cations as [11C]FMZ uptake (Yankam Njiwa et al., 2013); see Fig. 1a.
There were no signiﬁcant differences between SF and NSF patients
for other potential predictors of postoperative outcome. Results are il-
lustrated in Table 3.
3.2.2. Patient groups against controls restricted to WM periventricular sig-
nal increases
As expected, SF patients compared with controls showed a smaller
number of periventricular clusters, which were also less signiﬁcant,
than NSF patients for [18F]FDG. [18F]FDG showed a bigger cluster with
a higher z score (z= 4.16, 2.1 cm3) than [11C]FMZ had in our previous
study (Fig. 1b).
The group of NSFpatients comparedwith controls showed increased
FDG uptake in four clusters with higher z scores than SF patients: two
ipsilaterally (8.6 and 1.3 cm3, zmax = 4.19) and two contralaterally
(5.2 and 1.2 cm3, zmax = 4.68). Similarly, using [11C]FMZ, more clusters
of periventricular signal increases with higher z scores had been found
in NSF patients versus controls, compared with SF patients against con-
trols (Yankam Njiwa et al., 2013, Fig. 1c).
3.2.3. Random forest classiﬁer analyses of the entire brain volume
Random forest classiﬁers were independently applied to the avail-
able feature data corresponding to all available voxels (513,340/vol)
for both radiotracers.
3.2.4. NSF versus SF patient groups
For both FDG-PET and FMZ-PET, RF classiﬁcation was not able to
distinguish between NSF and SF patients. Performance results areDG static images, before and after normalization. In brackets are the student test values of
fore and after normalization is due to matrix size differences.
FMZ
trols NSF SF Controls
8 ± 652 1492 ± 300 (p = 0.03) 1562 ± 207 (p = 0.02) 1778 ± 256
4 ± 932 2183 ± 395 (p = 0.17) 2202 ± 279 (p = 0.09) 2409 ± 335
127J. Yankam Njiwa et al. / NeuroImage: Clinical 7 (2015) 122–131illustrated in Table 4. FMZ better performed than FDG for the classiﬁca-
tion of subjects, except for theNSF/SF comparison in terms of sensitivity.
3.2.5. Patient groups against controls
For the comparison between the group of patients and controls, RF
classiﬁers well correctly predicted 7/8 NSF using FMZ images and 6/8
with FDG. FMZ binding was more sensitive in differentiating SF toL
FMZ
R
(a
(b
(c
(d
) 
) 
) 
) 
Fig. 1. Periventricular increases and unmasked statistical results overlaid onto the SPM8 T1-wei
(2013) and shown for direct comparison. (a) Increases in non-seizure free patients (NSF; not En
and contralateral (zmax = 4.2, CE= 0.9 cm3) for FMZ and ipsilateral (zmax = 3.66, CE= 1.1 cm
patients, compared to controls (zmax=3.31, CE=0.25 cm3, ipsilateral) for FMZ and (zmax=4.1
is a normalization artefact appearing in both modalities. (c) NSF patients compared to controls
lateral) for FDG. (d) Periventricular signal increases in an individual patient (#15), with a subo
CE = 7.3 cm3, contralateral). Signiﬁcant clusters are pointed with green arrows.from controls (7/8 well correctly predicted) than FDG (6/8 well correct-
ly predicted).
With FMZ data, important features for distinguishing NSF patients
from controls consisted ofmorewidespread clusters detected principal-
ly in the hippocampus, whereas for SF patients those were somewhat
more concentrated in the amygdala and in the temporal lobe. Results
are shown in Fig. 2.FDG
 
ghted template. FDG results obtained for this study; FMZ results from Yankam Njiwa et al.
gel IA) compared to seizure-free patients; ipsilateral, left side, (zmax=2.69, CE=0.56 cm3)
3), contralateral (zmax = 3.37, CE= 0.4 cm3) for FDG. (b) Seizure free (SF; Engel class IA)
6, CE=2.12 cm3, ipsilateral) for FDG. The apparent increase near the superior sagittal sinus
(zmax = 5.25, CE= 5.25 cm3, ipsilateral) for FMZ and (zmax= 4.68, CE= 5.2 cm3, contra-
ptimal outcome, for FMZ (zmax = 4.01, CE= 3 cm3, ipsilateral), and for FDG (zmax = 5.11,
Table 3
Evaluation of the age at seizure onset, the duration of epilepsy and the age at operation as potential non-imaging predictors for epilepsy surgery outcome, in terms ofmedian, interquartile
distance, and Mann–Whitney U test (MWUT) values.
Mean[interquartile distance]
Predictor Age at onset Duration of epilepsy Age at operation
NSF 4.5 [6.5] 26 [15.3] 34 [8.3]
SF 5.0 [2.3] 24 [12.5] 28.5 [13]
MWUT (two tailed) 32.5 (p = 0.96) 32.5 (p = 0.96) 38.5 (p = 0.5)
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3.3.1. NSF versus SF patients: WM periventricular signal increases
After screening the cluster p values as mentioned in the Materials
and methods section, it resulted that considering clusters in the
periventricular mask fulﬁlling the condition of zmin = 3.2/pmax = 0.46
for [11C]FMZ, and zmin = 3.2/pmax = 0.5 for [18F]FDG best differentiate
SF and NSF patients, see Table 1.
Periventricular increases in individual patients occurred in similar
regions as in the group analyses. Under the optimal threshold condi-
tions described in the Materials and methods section and for the same
patients, ﬁve of eight NSF patients (63%) showed periventricular WM
signal increases with [18F]FDG, the same number as previously found
for [11C] FMZ (Yankam Njiwa et al., 2013, Table 5).
Four of eight SF patients showed periventricular signal increases
with [18F]FDG, whereas only one of eight SF patients had shown
periventricular increases with [11C]FMZ (Yankam Njiwa et al., 2013,
Table 5). In the context of this study, sensitivity corresponds to the frac-
tion of NSF patients correctly predicted to remain NSF, i.e. having
periventricular increases, and speciﬁcity corresponds to the fraction of
SF correctly predicted to become SF after the operation, i.e. patients
without periventricular increases. Hence, the test performed had
63% sensitivity / 50% speciﬁcity for [18F]FDG, compared with 63%
sensitivity / 88% speciﬁcity for [11C]FMZ. Table 1 and Table 5 show the
corresponding results and Fig. 1d illustrates areas of increased
periventricular [11C]FMZ binding and [18F]FDG uptake in an individual
NSF patient (Patient # 15).3.3.2. NSF versus SF patients: mesial temporal [18F]FDG hypometabolism
Six out of eight SF patients did have mesial temporal lobe
hypometabolism, and ﬁve out of eight NSF patients did not (Table 1).
The presence of ipsilateral mesial temporal lobe hypometabolism did
hence to a certain degree predict SF outcome, and its absence to a de-
gree predicted NSF outcome.3.3.3. Random forest classiﬁer analyses of the entire brain volume
For FMZ, the leave one out test performedwith 1000 trees led to ﬁve
out of eight true positive NSF predictions in NSF patients against 35 out
of 41 controls correctly predicted. The test alsowell predictedﬁve SF pa-
tients as SF and failed to predict six out of 30 controls.
In contrast, with FDG, the test predictedﬁve out of eight true positive
NSF and failed to well predict eleven controls. Fourteen controls were
not correctly predicted against four true positive SF patients.Table 4
Test performance of the SPM-based assessment of periventricular increases. SF, seizure
free (n= 8); NSF, not seizure free (n= 8); FMZ [11C]ﬂumazenil PET; FDG [18F]FDG PET.
The cells with a grey background indicate patients correctly classiﬁed.
Te
st
 o
ut
pu
t
Clinical outcome
SF NSF
SF FMZ 7/FDG 4 FMZ 3/FDG 3 
NSF FMZ 1/FDG 4 FMZ 5/FDG 5 4. Discussion
This study shows an association between periventricular WM in-
creases of [18F]FDG binding with NSF status after temporal resection
for HS. These results corroborate the observations previously made for
[11C]FMZ (Yankam Njiwa et al., 2013). For large numbers of control
datasets available, periventricular [11C]FMZ has previously been
shown to usefully predict individual postoperative outcome; here we
show that this is less the case for [18F]FDG uptake regarding
periventricular white matter increases.
Accuracies for distinguishing patients from controlswere larger than
0.8 for [11C]FMZ using RF classiﬁcation. However, this distinction is not
clinically meaningful. For the clinically important SF/NSF distinction,
[18F]FDG as well as [11C]FMZ performed roughly at chance level.
The previous study (Yankam Njiwa et al., 2013) showed that
summed [11C]FMZ radioactivity images, not requiring metabolite
corrected arterial plasma input functions, were sufﬁcient for predicting
surgery outcome in candidates with TLE based on periventricular WM
changes. An important ﬁnding of the current study is that the method
could in principle, with caution, also be applied to the more clinically
widely used FDG.
Increased [11C]FMZ/[18F]FDG signal likely indicates an increased
concentration of heterotopic neurons in the sense of a developmental
abnormality, i.e. MRI-invisible subependymal heterotopia (Hammers
et al., 2003) or a consequence of recurrent seizures. This may imply
the existence of a more widespread epileptogenic network beyond the
hippocampus and boundaries of the temporal lobes.
As illustrated in the Results section, the presence of ipsilateralmesial
temporal lobe hypometabolism to a certain degree predicted SF out-
come status, and its absence to a degree predicted NSF outcome.
However, the FMZ-based methods performed somewhat better. Inter-
estingly, the differentmethods failed to predict outcome in different pa-
tients, suggesting that the different tracers assess different aspects of
these patients3 epilepsies.
According to the classiﬁcation results computedwith random forests
classiﬁers, [11C]FMZ binding may reﬁne the prediction of surgery out-
come for temporal lobe epilepsy with HS, whilst this was not the case
with [18F]FDG uptake. The feature importance during RF analysis allows
the determination of voxels that have been useful for classiﬁcation. For
differentiating between the three clinical groups using voxel based [18F]
FDG-PET and [11C]FMZ-PET, hippocampal voxels were more important
for the classiﬁcation of NSF patients against controls using FMZ images.
In contrast, voxels located in the amygdala weremore important for the
classiﬁcation between SF patients and controls compared to NSF pa-
tients. Theseﬁndings are in linewith the regions expected to be affected
in temporal lobe epilepsy (Reid and Staba, 2014). Nevertheless the less-
er sensitivity of [18F]FDG may reﬂect the failure to detect signal differ-
ences in brain structures and could also explained by the absence of
local cluster representing important voxels.
These feature importances were highly interesting because voxels
were detected outside the periventricular areas, thus opening the door
to merge the results of the two methods. Combining RF classiﬁcation
with periventricular masking improved the prediction accuracy for
FMZ: If both were used for predicting NSF status and if either test pre-
dicted NSF status (data in Table 1), FMZwould correctly predict NSF sta-
tus in all NSF patients, but assign NSF prognosis incorrectly to 2/8 SF
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Fig. 2. Feature importances for differentiating between three clinical groups using voxel based FDG-PET (bottom) and FMZ-PET (top). Voxels important for distinguishing patients from
controls are overlaid onto an MNI-space FMZ-PET template (top) and FDG-PET template (bottom). Left column, non-seizure free patients; right column, seizure free patients.
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predictors for FDGwould not be useful, as all patients except two SF pa-
tients would be given the NSF prognosis.
Several studies have shown that temporal lobe hypometabolism
has postsurgical prognostic signiﬁcance; patients with at least 15%
hypometabolism were likely to become SF (Theodore et al., 1992;
Theodore et al., 1994). It has also been illustrated that mean lateral
but not mesial temporal asymmetry was signiﬁcantly higher in patients
who did become seizure free than those who did not (Theodore et al.,
1992). Here, we investigated relative hypermetabolism in the
periventricular white matter. For this feature, NSF patients had more
clusters than SF patients (Fig. 2). However, they were seen bilaterally
without marked asymmetry. This may reﬂect a mechanism acting on
both sides, either a developmental abnormality of migration (Gleeson
and Walsh, 2000) or a response to frequent seizures (Parent et al.,
2002). Other attempts to predict postsurgical outcome from pre-
surgical imaging data have also been recently discussed (Chassoux
et al., 2010; Feis et al., 2013; Yankam Njiwa et al., 2013). In addition,
atypical histological HS patterns, as for example damage restricted to
the hilar region, may predict poorer outcome (Blumcke et al., 2007; de
Lanerolle et al., 2003; Sagar and Oxbury, 1987). The same held trueTable 5
Performance results of the RF classiﬁer for binary classiﬁcations. Mean ± SD accuracy, sensitiv
mances are averaged over the number of trees for eachRF (1000:1000:10,000). NSF=not seizu
NSF/SF patients versus controls and in identifying NSF patients versus SF patients.
FDG
NSF/SF NSF/C SF/C
Accuracy 0.36 ± 0.03 0.66 ± 0.001 0.53 ± 0
Sensitivity 0.33 ± 0.06 0.74 ± 0.04 0.5 ± 0
Speciﬁcity 0.40 ± 0.05 0.63 ± 0.00 0.53 ± 0when HS patterns were analysed quantitatively (Thom et al., 2010).
The usefulness of the potential predictors is dependent on the assess-
ment time according to the operation and prognostic factors are also in-
terdependent (Janszky et al., 2005; Najm et al., 2013). Seizure
characteristics like high seizure frequency and a history of generalized
seizures have also been described as predictors of non-seizure free out-
come (Asztely et al., 2007; Janszky et al., 2005). In our study, seizure fre-
quencies had not been prospectively noted at the time of the scan in all
patients included, and given the long follow-up, it was not possible to
meaningfully reconstruct this information.
Previous studies have sometimes found that “mild” malformations
of cortical development, e.g. cortical lamination abnormalities in the
temporal lobe associated with HS (focal cortical dysplasia type IIIa ac-
cording to the 2011 ILAE classiﬁcation (Blumcke et al., 2011)) may not
inﬂuence postsurgical outcome in mTLE (Kuba et al., 2012). It is impor-
tant to note that such ﬁndings refer to abnormalities in surgical speci-
mens and hence, by deﬁnition, to subtle pathology that has been
removed and can therefore no longer contribute to ictogenesis, e.g. via
the “short-circuiting” described in animal models associated with het-
erotopic neurons (Chevassus-au-Louis et al., 1999). This is consistent
with our own previous studies, where temporal lobe white matterity and speciﬁcity for summed radioactivity images (FMZ) and FDG static images. Perfor-
re free, SF= seizure free, C= controls. Performance values of the RF classiﬁer in classifying
FMZ
NSF/SF NSF/C SF/C
.02 0.40 ± 0.06 0.83 ± 0.01 0.82 ± 0.01
.00 0.20 ± 0.06 0.76 ± 0.04 0.76 ± 0.04
.03 0.54 ± 0.08 0.85 ± 0.01 0.83 ± 0.01
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ated with suboptimal outcome in the contralateral temporal lobe
(Hammers et al., 2001). Similarly, in (Yankam Njiwa et al., 2013) and
the presentmanuscript we describe the same in vivo biomarker in a re-
mote area not removed during surgery.
Both tracers and methods did not always overlap in their prediction
of seizure status for individual patients. Periventricular WM signal in-
creases are not always seen at the same locations for both tracers.
[18F]FDG uptake assesses metabolism, a more general aspect of brain
function than the more speciﬁcally neuron-linked [11C]FMZ binding;
this could explain the fact that [18F]FDG uptake was less predictive of
outcome (see Table 1).
Other studies showed that the complete postoperative absence of
seizures widely varies with the considered postoperative time point
(Aull-Watschinger et al., 2008; Elsharkawy et al., 2009; Kelemen et al.,
2006). For example, in a study of 153 patients with MRI-diagnosed HS,
the gender, the seizure frequency before operation, and the unilaterality
of interictal EEG discharges were used as variables in a logistic regres-
sion equation for predicting outcome after surgery (Aull-Watschinger
et al., 2008). Complete seizure freedom (Engel class IA) could not be
predicted from conventional preoperative variables; our study provides
another element allowing such a prediction even if its accuracy remains
limited.
In summary, classiﬁcation based on RF performed slightly better
than the previousmethod based on periventricularWMsignal increases
for both used tracers. The accuracymay be sufﬁcient to aid in individual
preoperative counselling. However, the classiﬁer constructed will need
to be tested on an independent sample.Acknowledgement
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